Implementing GI-MAP Stool Testing in Clinical Practice
Presented by Dr. David Brady, Chief Medical Officer, Diagnostic Solutions Labs, Inc.
Learn how to assess overall gastrointestinal health by comprehensive molecular evaluation of the GI microbiome, gut inflammation and mucosal immunity, and digestive function. Diagnostic Solutions Lab offers the first FDA approved platform for the comprehensive evaluation of GI pathogens using molecular/PCR based techniques. In addition to the assessment of bacteria, protozoal, and viral pathogens, the lab also employs this technology to assess opportunistic and beneficial organisms. This is the true diagnostic solution for evaluating gut health.
This educational webinar is designed to enlighten the clinician with information on:
- When the GI-MAP should be considered?
- Interpretation of the microbiome, digestive function, and immune and inflammatory markers on the GI-MAP.
- The association and emerging causal data linking aberrant GI microbial patterns with various autoimmune disorders and how the GI-MAP can help.
- Diet and supplement recommendations based upon abnormal results on the GI-MAP.
- Case study presentations using the GI-MAP stool analysis
Dr. David M. Brady has over 25-years of experience as an integrative medical practitioner and academic. He is a licensed naturopathic medical physician in Connecticut and Vermont and a board certified clinical nutritionist. Dr. Brady is also a prolific author of medical papers and research articles on fibromyalgia and has dedicated a large part of his professional career to helping people recover from this mysterious disorder. He currently serves as the Vice President for Health Sciences, Director of the Human Nutrition Institute, and Associate Professor of Clinical Sciences at the University of Bridgeport in Connecticut. He maintains a private practice, Whole Body Medicine, in Fairfield, CT and is also the Chief Medical Officer for Designs for Health, Inc. and Diagnostic Solutions Labs, LLC. You can learn more at DrDavidBrady.com, FibroFix.com, and FibroFixSummit.com.
1. Understand the basic pathophysiology regarding the link between the GI environment and many systemic diseases.
2. Appreciate the linkage between the status of the GI microbiota and the genesis of various systemic diseases not conventionally recognized as having linkage to the gastrointestinal system.
3. Understand the relationship between nutrition and recovery from systemic diseases with GI linkage.
4. Explain the role of molecular mimicry in the genesis of autoimmune diseases will be fully explored.
5. Describe the novel diagnostic modalities and functional/metabolic objective laboratory assays available related to the clinical conditions listed above.
6. List the available therapeutic interventions for various systemic diseases having linkage to the gastrointestinal system.
Supporting Presenter-Authored Publications:
Brady, DM. Molecular Mimicry, the Hygiene Hypothesis, Stealth Infections, and Other Examples of Disconnect Between Medical Research and the Practice of Clinical Medicine. Open Journal of Rheumatology. Vol. 3, No. 1, Feb. 2013.
Mullin GE (Editor): Integrative Gastroenterology. Brady D: Chapters; Gastrointestinal Disorders and Fibromyalgia; and Alternative Laboratory Testing for Gastrointestinal Disorders. 2011. Oxford Press, Weil Integrative Medicine Library, New York, NY.
Townsend Letter: Autoimmune Disease-A Modern Epidemic: Molecular Mimicry, the Hygiene Hypothesis, Stealth Infections, and Other Examples of Disconnect Between Medical Research and the Practice of Clinical Medicine. Issue 347, June 2012.
Naturopathic Doctor News & Review: DNA Detection of Gut Microbiota Using Polymerase Chain Reaction (PCR) Technology. Volume 4, Issue 1, Jan. 2008.
Diagnostics Spotlight: DNA-PCR-based stool analysis. Journal of Complementary Medicine, 2008, July/August, 28-31.
Novel Options in Gastrointestinal Diagnostics. Nutr Perspectives 2008; Vol 31, No 3, 5-7.